Publications (751) Publications in which a researcher has participated

2017

  1. 2016 ESC/EAS guidelines for the management of dyslipidemias

    Revista Espanola de Cardiologia, Vol. 70, Núm. 2, pp. 115.e-115.e

  2. 3-Oxopyridazin-5-yl-Chalcone Hybrids: Potent Antiplatelet Agents That Prevent Glycoprotein IIb/IIIa Activation

    ChemistrySelect, Vol. 2, Núm. 17, pp. 4920-4933

  3. 3-iodothyronamine induces tail vasodilation through central action in male mice

    Endocrinology, Vol. 158, Núm. 6, pp. 1977-1984

  4. A Brief History. Impact of the Advances in Ischaemic Heart Disease

    Revista Espanola de Cardiologia Suplementos, Vol. 17, pp. 2-6

  5. A Global Declaration on Appropriate Use of Antimicrobial Agents across the Surgical Pathway

    Surgical Infections, Vol. 18, Núm. 8, pp. 846-853

  6. A Positive Allosteric Modulator of the Serotonin 5-HT2C Receptor for Obesity

    Journal of Medicinal Chemistry, Vol. 60, Núm. 23, pp. 9575-9584

  7. A Prospective Observational Study for Assessment and Outcome Association of Circulating Endothelial Cells in Clear Cell Renal Cell Carcinoma Patients Who Show Initial Benefit from First-line Treatment. The CIRCLES (CIRCuLating Endothelial cellS) Study (SOGUG-CEC-2011-01)

    European Urology Focus, Vol. 3, Núm. 4-5, pp. 430-436

  8. A brain-sparing diphtheria toxin for chemical genetic ablation of peripheral cell lineages

    Nature Communications, Vol. 8

  9. A breath ammonia analyser for monitoring patients with end-stage renal disease on haemodialysis

    British Journal of Biomedical Science, Vol. 74, Núm. 1, pp. 24-29

  10. A combined large-scale meta-Analysis identifies COG6 as a novel shared risk locus for rheumatoid arthritis and systemic lupus erythematosus

    Annals of the Rheumatic Diseases, Vol. 76, Núm. 1, pp. 286-294

  11. A fatal drug interaction

    Medicina Clinica, Vol. 149, Núm. 9, pp. e47

  12. A high-resolution map of transcriptional repression

    eLife, Vol. 6

  13. A new panel of SNPs to assess thyroid carcinoma risk: A pilot study in a Brazilian admixture population

    BMC Medical Genetics, Vol. 18, Núm. 1

  14. A new scenario in the immunohistochemical diagnosis of cutaneous leishmaniasis

    Journal of Cutaneous Pathology, Vol. 44, Núm. 12, pp. 1051-1052

  15. A quantitative assessment of the evolution of cerebellar syndrome in children with phosphomannomutase-deficiency (PMM2-CDG)

    Orphanet Journal of Rare Diseases, Vol. 12, Núm. 1

  16. A randomised, double-blind trial to demonstrate bioequivalence of GP2013 and reference rituximab combined with methotrexate in patients with active rheumatoid arthritis

    Annals of the Rheumatic Diseases, Vol. 76, Núm. 9, pp. 1598-1602

  17. A randomized phase II/III study of cabazitaxel versus vinflunine in metastatic or locally advanced transitional cell carcinoma of the urothelium (SECAVIN)

    Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 28, Núm. 7, pp. 1517-1522

  18. A replication study and meta-analysis of mitochondrial DNA variants in the radiographic progression of knee osteoarthritis

    Rheumatology (United Kingdom), Vol. 56, Núm. 2, pp. 263-270

  19. A selective screening program for the early detection of mucopolysaccharidosis: Results of the FIND project-A 2-year follow-up study

    Medicine (United States), Vol. 96, Núm. 19

  20. A simple dressing for hypospadias surgery in children

    Canadian Urological Association Journal, Vol. 11, Núm. 1-2, pp. E58-E59